Micro-Chemical Solutions Nadeem Mazen B New Enterprises Executive Summary Presentation April 6, 2004 Revolutionizing laboratory chemistry

Micro-Chemical Solutions provides an integrated micro-chemistry system (MCS) Flexible, Easy-to-use Easy to develop new reactions Modular, plug-and-play functionality Safer Precise control over reactions Use of smaller quantities of reagents Cheaper More efficient (save on material cost) Highly automated – fewer chemists Less time to setup and scale up Reactor

Market Potential: Many industries; R&D and Production Initial Target Market: Pharma Large R&D spending, few major companies, focus on improved R&D efficiency, proven need in production R&D market alone is $40 million $4 billion spent on production instruments

MCS’s patented technology has significant competitive advantages Competitive advantages: Strong IP position Silicon reactors Greater temperature range and control Inert Easy to manufacture Integrated analytics

Experienced team has proven technology and initial partnership CEO: 20 years experience in pharma and 3 successful startups CTO/Founder: Developed technology, Prof. of Chemical Engineering & Materials Science and Engineering, Director of MIT MicroChemical Systems Technology Center VP Product Development: 10 years in Analytical Instruments VP Sales: 10 years sales in Analytical Instruments Partnership with GlaxoSmithKline

$5M needed to reach profitability Milestones Aug 2004 – Manufacturable prototype Oct 2004 – 1 st Round funding Dec 2004 – Complete GSK beta test Mar 2005 – initial production launch 2007 – Breakeven